Signature Financial Management’s CervoMed CRVO Stock Holding History

Signature Financial Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11	Closed	-$5K	–	137
2018 Q3	$5K	Hold	11	–	–	﹤0.01%	160
2018 Q2	$6K	Hold	11	–	–	﹤0.01%	167
2018 Q1	$7K	Hold	11	–	–	﹤0.01%	160
2017 Q4	$15K	Hold	11	–	–	﹤0.01%	113
2017 Q3	$21K	Hold	11	–	–	0.01%	170
2017 Q2	$29K	Buy	+11	New	+$35.4K	0.01%	156

Other funds holding CRVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SRCM

Swift Run Capital Management Charlottesville, Virginia $51.8M AUM 6.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Signature Financial Management's CRVO Position: Q4 2018 in Review

Signature Financial Management sold out of CervoMed (CRVO) in Q4 2018, closing a stake of 11 shares — an estimated $5K sold.

Signature Financial Management first reported a position in CRVO in Q2 2017 and held it in 6 quarters. The position peaked at $29K in Q2 2017. 11 funds tracked by Wall St. Rank hold CRVO as of Q4 2018.

Signature Financial Management reported no remaining CervoMed position as of Q4 2018 after selling out during the quarter.
Signature Financial Management sold 11 CervoMed shares in Q4 2018, an estimated $5K.
Signature Financial Management first reported a position in CervoMed in Q2 2017 and held it in 6 quarters.
Signature Financial Management's CervoMed position peaked at $29K in Q2 2017.
11 funds tracked by Wall St. Rank held CervoMed as of Q4 2018.

Based on Signature Financial Management's 13F filing for Q4 2018, filed 13 Feb 2019.